Similar articles for PMID: 18041358

Year	Number of Results
1988	1
1989	1
1996	2
1997	2
1999	2
2000	3
2001	1
2002	1
2003	2
2004	3
2005	5
2006	2
2007	4
2008	3
2009	9
2010	5
2011	3
2012	2
2013	4
2014	4
2015	2
2016	2
2019	1
2020	1
2024	0

1

Quality of life evaluation by the EORTC QLQ-C30 questionnaire in patients treated with hormonal treatment in Italy. A QuABIOS group study.

Prezioso D, Bartoletti R, Cecchi M, Cicalese V, Cunico SC, Damiano R, De Lisa A, Franzolin N, Frea B, Guazzoni G, Mearini E, Morgia G, Muzzonigro G, Oliva G, Orestano F, Pagliarulo A, Pappagallo GL, Parma P, Perachino M, Pompa P, Rocco F, Zattoni F; QuABIOS Study Group. Prezioso D, et al. Arch Ital Urol Androl. 2007 Sep;79(3):99-103. Arch Ital Urol Androl. 2007. PMID: 18041358

2

Hormonal treatment for prostate cancer in Italy. Preliminary data from a survey of the QUABIOS Group.

Prezioso D, Pappagallo GL, Guazzoni G, Orestano F, Zattoni F; QUABIOS Group. Prezioso D, et al. Arch Ital Urol Androl. 2006 Mar;78(1):15-9. Arch Ital Urol Androl. 2006. PMID: 16752882

3

Health-related quality of life in patients with hormone refractory prostate cancer receiving gefitinib.

Curigliano G, Spitaleri G, De Cobelli O, Scardino E, Sbanotto A, de Braud F. Curigliano G, et al. Urol Int. 2009;82(2):196-202. doi: 10.1159/000200800. Epub 2009 Mar 19. Urol Int. 2009. PMID: 19322010 Clinical Trial.

4

Combined androgen blockade (CAB) versus luteinizing hormone-releasing hormone (LHRH) agonist monotherapy for androgen deprivation therapy.

Park HS, Shin HB, Woo SH, Jeon SH, Lee SH, Kang SH, Shim JS, Shin DW, Park J. Park HS, et al. World J Urol. 2020 Apr;38(4):971-979. doi: 10.1007/s00345-019-02847-y. Epub 2019 Jun 11. World J Urol. 2020. PMID: 31187203 Clinical Trial.

5

[Quality of life of patients with prostate cancer under androgen deprivation with GnRH analogues: Results of the noninterventional study TRIPTOSIX].

Eisenhardt A, Schneider T, Scheithe K, Colling C, Heidenreich A; TRIPTOSIX-Studiengruppe. Eisenhardt A, et al. Urologe A. 2016 Feb;55(2):176-83. doi: 10.1007/s00120-015-3989-7. Urologe A. 2016. PMID: 26518305 Clinical Trial. German.

6

Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.

Sakai H, Igawa T, Tsurusaki T, Yura M, Kusaba Y, Hayashi M, Iwasaki S, Hakariya H, Hara T, Kanetake H. Sakai H, et al. Urology. 2009 Mar;73(3):635-40. doi: 10.1016/j.urology.2008.09.013. Epub 2008 Nov 26. Urology. 2009. PMID: 19038426 Free article. Clinical Trial.

7

Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.

Park J, Shin DW, Yun SJ, Park SW, Jeon SS, Kwak C, Kwon TG, Kim HJ, Ahn H. Park J, et al. Oncology. 2013;85(5):299-305. doi: 10.1159/000355689. Epub 2013 Nov 6. Oncology. 2013. PMID: 24217330

8

Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.

Irani J, Salomon L, Oba R, Bouchard P, Mottet N. Irani J, et al. Lancet Oncol. 2010 Feb;11(2):147-54. doi: 10.1016/S1470-2045(09)70338-9. Epub 2009 Dec 4. Lancet Oncol. 2010. PMID: 19963436 Clinical Trial.

9

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

Calais da Silva FE, Bono AV, Whelan P, Brausi M, Marques Queimadelos A, Martin JA, Kirkali Z, Calais da Silva FM, Robertson C. Calais da Silva FE, et al. Eur Urol. 2009 Jun;55(6):1269-77. doi: 10.1016/j.eururo.2009.02.016. Epub 2009 Feb 21. Eur Urol. 2009. PMID: 19249153 Clinical Trial.

10

Intermittent androgen suppression in the treatment of metastatic prostate cancer.

Bouchot O, Lenormand L, Karam G, Prunet D, Gaschignard N, Malinovsky JM, Buzelin JM. Bouchot O, et al. Eur Urol. 2000 Nov;38(5):543-9. doi: 10.1159/000020353. Eur Urol. 2000. PMID: 11096234 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

57 results

Results by year